Takeda Pharmaceutical Company (C): The Future of Takeda Harvard Case Solution & Analysis

In addition to the acquisition of Millennium Pharmaceuticals in 2008 and Amgen Japan in 2009, Takeda implemented a major reorganization of its global organization. President Yasuchika Hasegawa Takeda reorganized business in the U.S. and is rapidly expanding its global business. For the first time in the history of Takeda, Hasegawa appointed several non-Japanese to positions and left the Japanese-oriented control system. Hasegawa was confident that Takeda was to become a global company and the transition to his vision of innovation, cultural change and economic growth. "Hide
by Charles O'Reilly, Asaka Ito, Hiromichi Kimura, Chris D Beaumont, Robert Kneller Source: Stanford Graduate School of Business 4 pages. Publication Date: Mar 06, 2012. Prod. #: OB83C-PDF-ENG

Takeda Pharmaceutical Company (C): The Future of Takeda Case Solution Other Similar Case Solutions like

Takeda Pharmaceutical Company (C): The Future of Takeda

Share This